Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A resurgence of Pneumocystis in aggressive lymphoma treated with R-CHOP-14: the price of a dose-dense regimen?

× No keyword cloud information.

6 in total

1. Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma.

Authors: Jason N Barreto; Carrie A Thompson; Patrick M Wieruszewski; Amanda G Pawlenty; Kristin C Mara; Ashley L Potter; Pritish K Tosh; Andrew H Limper
Journal: Leuk Lymphoma Date: 2020-07-05

2. Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.

Authors: Gaetano Corazzelli; Ferdinando Frigeri; Manuela Arcamone; Anna Lucania; Maria Rosariavilla; Emanuela Morelli; Alfonso Amore; Gaetana Capobianco; Antonietta Caronna; Cristina Becchimanzi; Francesco Volzone; Gianpaolo Marcacci; Filippo Russo; Rosaria De Filippi; Lucia Mastrullo; Antonio Pinto
Journal: Br J Haematol Date: 2011-06-28 Impact factor: 6.998

Review 3. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis.

Authors: Xuqin Jiang; Xiaodong Mei; Di Feng; Xiaojing Wang
Journal: PLoS One Date: 2015-04-24 Impact factor: 3.240

4. Pneumocystis jirovecii pneumonia in non-Hodgkin's lymphoma after rituximab-based chemotherapy: a case series.

Authors: Qianying Zhang; Liang Han; Yuanyuan Lin; Xiaohong Sun; Haige Ye; Honglan Qian; Lan Sun; Songfu Jiang; Bin Liang
Journal: Transl Cancer Res Date: 2022-07 Impact factor: 0.496

5. Prophylactic antibiotic treatment with TMP-SMX decreased the incidence of interstitial pneumonia in patients with B-cell lymphoma on chemotherapy.

Authors: Cong Li; Fangxiao Lu; Tao Lei; Haifeng Yu; Xi Chen; Shuailing Peng; Shuiyun Han; Haiyan Yang
Journal: BMC Cancer Date: 2020-08-08 Impact factor: 4.430

6. RCHOP-14 therapy versus RCHOP-21 therapy for people with aggressive or advanced-stage indolent B-cell non-Hodgkins lymphoma: a systematic review and meta-analysis.

Authors: Yue He; Wenqiang Tao; Dexiang Ji; Wei Lu; Yu Xiong; Guoan Chen
Journal: Transl Cancer Res Date: 2021-05 Impact factor: 1.241

6 in total